{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:59:01Z","timestamp":1790863141522,"version":"4.1.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/inf.0b013e318199f61b","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T14:33:20Z","timestamp":1242916400000},"page":"S97-S108","source":"Crossref","is-referenced-by-count":78,"title":["Immunogenicity of Routinely Used Childhood Vaccines When Coadministered With the 10-Valent Pneumococcal Non-typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV)"],"prefix":"10.1097","volume":"28","author":[{"given":"Markus","family":"Knuf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Szenborn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masnuel","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Bermal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Dieussaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lode","family":"Schuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210202","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1542\/peds.112.4.958","article-title":"Standards for child and adolescent immunization practices.","volume":"112","year":"2003","journal-title":"Pediatrics"},{"key":"R2-5-20210202","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00006454-199405000-00012","article-title":"Simultaneous administration of childhood vaccines: an important public health policy that is safe and efficacious.","volume":"13","author":"King","year":"1994","journal-title":"Pediatr Infect Dis J"},{"issue":"RR-15","key":"R3-5-20210202","first-page":"1","article-title":"Advisory Committee on Immunization Practices (ACIP), Centers for Disease Control and Prevention (CDC). General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"R4-5-20210202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1586\/14760584.7.1.97","article-title":"Combination vaccines containing DTPa-Hib: impact of IPV and coadministration of CRM197 conjugates.","volume":"7","author":"Dagan","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"R8-5-20210202","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"R9-5-20210202","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.vaccine.2005.11.021","article-title":"Assessment of the compatibility of co-administered 7-valent pneumococcal conjugate, DTaP. IPV\/PRP-T Hib and hepatitis B vaccines in infants 2\u20137 months of age.","volume":"24","author":"Scheifele","year":"2006","journal-title":"Vaccine"},{"key":"R10-5-20210202","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1016\/j.vaccine.2007.11.096","article-title":"Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants.","volume":"26","author":"Olivier","year":"2008","journal-title":"Vaccine"},{"key":"R11-5-20210202","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.inf.0000148923.46453.48","article-title":"Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate vaccine.","volume":"24","author":"Tichmann-Schumann","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R12-5-20210202","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1097\/00006454-200009000-00009","article-title":"Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type B conjugate vaccine in United Kingdom infants.","volume":"19","author":"Choo","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R14-5-20210202","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1099\/00222615-25-4-279","article-title":"Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with the toxin neutralisation test.","volume":"25","author":"Melville-Smith","year":"1988","journal-title":"J Med Microbiol"},{"key":"R15-5-20210202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0092-1157(83)80038-9","article-title":"A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera.","volume":"11","author":"Melville-Smith","year":"1983","journal-title":"J Biol Stand"},{"key":"R16-5-20210202","first-page":"443","article-title":"Progress in the control of viral hepatitis: memorandum from a WHO Meeting.","volume":"66","year":"1988","journal-title":"Bull World Health Organ"},{"key":"R17-5-20210202","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1093\/infdis\/149.6.1034","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"149","author":"Anderson","year":"1984","journal-title":"J Infect Dis"},{"key":"R18-5-20210202","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/infdis\/147.6.1100","article-title":"The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b.","volume":"147","author":"K\u00e4yhty","year":"1983","journal-title":"J Infect Dis"},{"key":"R19-5-20210202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/BF02097184","article-title":"Acellular pertussis vaccine in adults: adverse reactions and immune response.","volume":"6","author":"Granstr\u00f6m","year":"1987","journal-title":"Eur J Clin Microbiol"},{"key":"R21-5-20210202","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays.","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"key":"R22-5-20210202","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection \u2013 serum bacterial antibody activity.","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"key":"R23-5-20210202","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicentre comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"key":"R24-5-20210202","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2165\/00003495-199855030-00003","article-title":"Meningococcal vaccines. Current status and future possibilities.","volume":"55","author":"Peltola","year":"1998","journal-title":"Drugs"},{"key":"R25-5-20210202","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of binomial.","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"R28-5-20210202","doi-asserted-by":"crossref","first-page":"198","DOI":"10.4161\/hv.1.5.2163","article-title":"A new DTPw-HBV\/Hib vaccine is immunogenic and safe when administered according to the EPI (Expanded Programme for Immunization) schedule and following hepatitis B vaccination at birth.","volume":"1","author":"Gatchalian","year":"2005","journal-title":"Hum Vaccin"},{"key":"R29-5-20210202","first-page":"772","article-title":"The new DTPw-HBV-Hib combination vaccine can be used at the WHO schedule with a monovalent dose of hepatitis B vaccine at birth.","volume":"29","author":"Bravo","year":"1998","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"R30-5-20210202","first-page":"153","article-title":"A hexavalent DTPa-HBV-IPV\/Hib vaccine administered to Filipino infants at 6, 10, and 14 weeks of and 12\u201315 months of age; importance of the birth dose of HBV.","volume":"56","author":"Gatchalian","year":"2007","journal-title":"Philipp J Pediatr"},{"key":"R31-5-20210202","first-page":"505","article-title":"Immunogenicity and safety of combined diphtheria tetanus whole cell pertussis hepatitis B\/ Haemophilus influenzae type b vaccine in Indian infants.","volume":"44","author":"Bavdekar","year":"2007","journal-title":"Indian Pediatr"},{"key":"R32-5-20210202","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1128\/IAI.66.5.2093-2098.1998","article-title":"Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.","volume":"66","author":"Dagan","year":"1998","journal-title":"Infect Immun"},{"key":"R33-5-20210202","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/01.inf.0000207483.60267.e7","article-title":"Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.","volume":"25","author":"Goldblatt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R34-5-20210202","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1016\/j.vaccine.2006.03.032","article-title":"Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV\/Hib combination vaccine in healthy infants.","volume":"24","author":"Knuf","year":"2006","journal-title":"Vaccine"},{"key":"R35-5-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vaccine.2005.07.060","article-title":"Immunogenicity of one, two, or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP\/Hib vaccine.","volume":"24","author":"Southern","year":"2006","journal-title":"Vaccine"},{"key":"R36-5-20210202","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/adc.2005.076109","article-title":"Evaluation of a diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae type b vaccine given concurrently with meningococcal group C conjugate vaccine at 2, 3 and 4 months of age.","volume":"92","author":"Kitchin","year":"2007","journal-title":"Arch Dis Child"},{"key":"R37-5-20210202","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/01.inf.0000227725.61495.c4","article-title":"Immunogenicity and reactogenicity of primary immunization with a hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio-Haemophilus influenzae type B vaccine coadministered with two doses of a meningococcal C-tetanus toxoid conjugate vaccine.","volume":"25","author":"Tejedor","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R39-5-20210202","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/CVI.00377-06","article-title":"Immunogenicity, reactogenicity, and immune memory after primary vaccination with a novel Haemophilus influenzae-Neisseria meningitidis serogroup C conjugate vaccine.","volume":"14","author":"Schmitt","year":"2007","journal-title":"Clin Vaccine Immunol"},{"key":"R40-5-20210202","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/314753","article-title":"Meningococcal serogroup C conjugate vaccine is immunogenic in infancy and primes for memory.","volume":"179","author":"Richmond","year":"1999","journal-title":"J Infect Dis"},{"key":"R41-5-20210202","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1128\/IAI.71.10.5549-5555.2003","article-title":"Immunogenicity of, and immunologic memory to, a reduced primary schedule of meningococcal C-tetanus toxoid conjugate vaccine in infants in the United Kingdom.","volume":"71","author":"Borrow","year":"2003","journal-title":"Infect Immun"},{"key":"R42-5-20210202","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1201-9712(03)90011-7","article-title":"Facilitating the WHO expanded program of immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine.","volume":"7","author":"Ar\u00edstegui","year":"2003","journal-title":"Int J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006454-200904001-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T18:45:39Z","timestamp":1710355539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-200904001-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e318199f61b","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}